Search Results - "Qayed M"

Endotheliopathy syndromes, TA-TMA, and SOS, are risk factors for morbidity and mortality in critically ill pediatric hematopoietic cell transplant recipients.

Authors: Goel S Frost E Tarquinio K et al.

Source: Frontiers in oncology [Front Oncol] 2025 Sep 03; Vol. 15, pp. 1642939. Date of Electronic Publication: 2025 Sep 03 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

The First Gene Therapy for Treating an Indonesian Child with Thalassemia Major: A New Hope for Indonesia.

Authors: Tehuteru, Edi Setiawan Lim, Teck Onn Edhy, Anky Tri Rini Kusumaning et al.

Source: Thalassemia Reports. Mar2026, Vol. 16 Issue 1, p1. 5p.

The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer.

Authors: Schultz L McNerney K Lamble AJ et al.

Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2026 Apr; Vol. 23 (4), pp. 260-278. Date of Electronic Publication: 2026 Jan 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE

Unraveling the care pathway for CAR T-cell therapy in large B-cell lymphoma: insights from a nationwide study in France (2018–2023).

Authors: Thieblemont, C. Caillot, D. Pierre, Morgane et al.

Source: Leukemia & Lymphoma. Jun2026, Vol. 67 Issue 7, p1595-1606. 12p.

Quality of Life in CAR-T Cell Therapy.

Authors: Alati, Caterina Pitea, Martina Porto, Gaetana et al.

Source: Hematology Reports. Jun2026, Vol. 18 Issue 3, p40. 25p.

Global Epidemiology of Post-Transplant Lymphoproliferative Disorder (PTLD) in Hematopoietic Stem Cell Transplantation (HSCT): A Systematic Review and Meta-Analysis of Incidence, Subtypes, Risk Factors, and Beyond.

Authors: Khandker, Shahad Saif Pranto, Alif Hasan Juthy, Afrin Rahman et al.

Source: Journal of Clinical Medicine. May2026, Vol. 15 Issue 10, p3867. 20p.

Measurable Residual Disease in Adult Acute B-Lymphoblastic Leukemia: Methods, Guidelines, and Emerging Actionability at Ultra-Low-Level.

Authors: Yaseen, Abeer Abusalim, Enas Harb, Mohamad et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1331. 19p.

Predictive biomarkers validation of CD3⁺ cell apheresis yield in CAR-T manufacturing for diffuse large B-cell lymphoma: a machine learning approach.

Authors: Carbonell, Diego Rodríguez-Sosa, Alejandra Gómez-Serrano, Leticia et al.

Source: Scientific Reports. 11/28/2025, Vol. 15 Issue 1, p1-10. 10p.

Anti-CD19 chimeric antigen receptor T-cell therapy in a highly sensitized patient with focal and segmental glomerulosclerosis.

Authors: Guzzo, Isabella Becilli, Marco Cappoli, Andrea et al.

Source: Pediatric Nephrology. Nov2025, Vol. 40 Issue 11, p3513-3519. 7p.

CD19-Negative Acute Lymphoblastic Leukemia (ALL): A Case Report and Review of Literature on a Rare Phenomenon De Novo and a Future Induced Struggle in Relapse.

Authors: Arrabito, Marta Cannata, Emanuela Samperi, Piera et al.

Source: International Journal of Molecular Sciences. Apr2026, Vol. 27 Issue 7, p3203. 10p.

Minimal Residual Disease in Oncology: From Cure to Longitudinal Patient Management.

Authors: Kim, Jinhee Morceau, Franck Kwon, Yong-Jun et al.

Source: Cancers. Apr2026, Vol. 18 Issue 7, p1049. 25p.

Integrated Multi-Omic Analysis Reveals Novel Subtype-Specific Regulatory Interactions in Pediatric B-Cell Acute Lymphoblastic Leukemia.

Authors: Pushel, Irina Clark, Zachary S. Lansdon, Lisa A. et al.

Source: Cancers. Mar2026, Vol. 18 Issue 5, p813. 21p.

In Vitro Purging of Acute Lymphoblastic Leukemia (B-ALL) Cells with the Use of PTL, DMAPT, or PU-H71.

Authors: Ortiz-Reyes, Ana Elenka García-Sánchez, Sergio Serrano, Montserrat et al.

Source: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 21, p11707. 14p.

Long-term outcomes and GVHD in allogeneic hematopoietic cell transplantation abroad: a 14-year UAE multi-center cohort.

Authors: Syed N Abuhaleeqa M Kaabi FMA et al.

Source: BJC reports [BJC Rep] 2026 Jul 14; Vol. 4 (1). Date of Electronic Publication: 2026 Jul 14.

Publication Type: Journal Article

Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918752188106676 Publication Model: Electronic Cited Medium: Internet ISSN: 2731-9377 (Electronic) Linking ISSN: 27319377 NLM ISO Abbreviation: BJC Rep Subsets: PubMed not MEDLINE

Spatio-temporal kinetics of patients' CAR-T cells in blood and serous cavity effusion: real-world clinical insights.

Authors: Zhang, Man Chen, Caixia Fang, Yuekun et al.

Source: Cellular Oncology (2211-3428). Dec2025, Vol. 48 Issue 6, p1955-1969. 15p.

Cell Therapy for Spinal Cord Injury: Mechanistic Insights and Translational Challenges.

Authors: Bach DH Van Giang B Nguyen TL

Source: Cellular and molecular neurobiology [Cell Mol Neurobiol] 2026 Apr 12; Vol. 46 (1). Date of Electronic Publication: 2026 Apr 12.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 8200709 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-6830 (Electronic) Linking ISSN: 02724340 NLM ISO Abbreviation: Cell Mol Neurobiol Subsets: MEDLINE

Identification of leukemia-enriched signature through the development of a comprehensive pediatric single-cell atlas.

Authors: Mumme HL Huang C Ohlstrom D et al.

Source: Nature communications [Nat Commun] 2025 May 02; Vol. 16 (1), pp. 4114. Date of Electronic Publication: 2025 May 02.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

细胞程序性死亡配体 1 过表达增强人脐带间充质基质细胞的 T 细胞免疫抑制能力.

Alternate Title: Overexpression of programmed death ligand 1 enhances immunosuppressive capacity of human umbilical cord mesenchymal stromal cells against T cells.

Authors: 梁紫涵 王 蕊 孙 蕾 et al.

Source: Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu. 7/8/2026, Vol. 30 Issue 19, p4873-4881. 9p.

CD22 as a Target for Hematological Malignancies and Autoimmune Diseases.

Authors: Chen, Xin Zhang, Jiayi Chen, Sizhuo et al.

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 12, p5406. 21p.

From Resistance to Vulnerability: Therapy-Induced Surface Receptor Plasticity in ALL as an Immunotherapeutic Opportunity.

Authors: Ehm, Patrick A. H. Rehbach, Christoph

Source: Hemato. Jun2026, Vol. 7 Issue 2, p14. 42p.